The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.
<h4>Objective</h4>[corrected] To improve the biologic understanding of the Polycystic Ovarian Syndrome (PCOS) condition by examining the circadian variation and relationship between Anti Müllerian Hormone (AMH), gonadotropins and ovarian steroids in PCOS patients compared to normally ovu...
Guardado en:
Autores principales: | Leif Bungum, Florencia Franssohn, Mona Bungum, Peter Humaidan, Aleksander Giwercman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/80d044d9c68a42ae9329dfdcd04e4097 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
por: Ran Y, et al.
Publicado: (2021) -
Comparison of Tamoxifen and Clomiphene on Ovulation and Pregnancy Rates in Polycystic Ovary Syndrome Patients
por: S Esmaeilzadeh,, et al.
Publicado: (2009) -
Induction ovulation with use of low dose HMG in patients with Clomiphene Citrate resistant polycystic ovary syndrome (PCOs)
por: T Nazari, et al.
Publicado: (2003) -
Interpretation and significance of the definition of anti-Mullerian hormone in the practice of juvenile gynaecologist
por: Zaira K. Kumykova, et al.
Publicado: (2021) -
Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: a network meta-analysis
por: Yiping Yu, et al.
Publicado: (2017)